Another study showed that, MicroRNA-608 could sensitize cisplatin therapy of non-small cell lung cancer cells by targeting TEAD2, and overexpression of TEAD2 reduced miR-608-induced apoptosis of A549 cells under cisplatin (161). Here, TEAD2 is linked to non-small cell lung carcinoma.